Recent Posts
- NeonMind Purchases GMP Grade Synthetic Psilocybin from Psygen Labs for Phase 2 Human Clinical Trial
- NeonMind Submits Applications to Health Canada for Product Formulas to Support Cognitive and Immune Function and to Fight Stress
- NeonMind Appoints Robert Tessarolo as President and Chief Executive Officer
- NeonMind Lists on the Frankfurt Stock Exchange (FSE: 6UF)
- NEONMIND APPOINTS DR. FRANK RUSSO TO LEAD MUSIC-BASED PROGRAM
Recent Comments